Rifaximin + Ornidazole Tablet PCD Pharma Franchise Delhi

Rifaximin + Ornidazole Tablet Manufacturing Company Hyderabad

Rifaximin + Ornidazole Tablet Gastro Care Franchise Pune

Rifaximin + Ornidazole Tablet Pharma Supplier Jaipur

Rifaximin + Ornidazole Tablet Export Company Ahmedabad
Rifaximin + Ornidazole Tablet Franchise Opportunity Bangalore

Home/Products /rifaximin-200mg-ornidazole-400mg-tablet

About the Product

Description


Rifaboly O Tablet combines Rifaximin and Ornidazole, two powerful antibiotics that work together to treat infections in the stomach and intestines. Rifaximin targets harmful bacteria in the gut, while Ornidazole fights both bacteria and certain parasites. This combination is often used for diarrhea, gastroenteritis, and other intestinal infections, helping relieve symptoms like loose stools, cramps, bloating, and abdominal discomfort.

Mostly mild and temporary. Some people may experience nausea, stomach pain, metallic taste, dizziness, or headache. Rarely, allergic reactions or severe diarrhea can occur.

Treatment of intestinal infections caused by bacteria or parasites Management of traveler’s diarrhea and gastroenteritis

Take the medicine only as prescribed by your doctor. Complete the full course even if you start to feel better to avoid antibiotic resistance. Drink enough fluids to stay hydrated. Inform your doctor if you are pregnant, breastfeeding, or have liver problems before starting this medicine.

Keep in a cool, dry place below 30°C, away from sunlight and moisture. Store out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Rifaximin 200mg + Ornidazole 400mg Tablet in the PCD pharma franchise market?

Rifaximin 200mg + Ornidazole 400mg Tablet has strong demand in the gastroenterology, anti-infective, and general medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on gastrointestinal and antimicrobial portfolios.

Why should medical distributors include Rifaximin 200mg + Ornidazole 400mg Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for gastrointestinal infection management under medical supervision. Rifaximin 200mg is a poorly absorbed intestinal antibiotic that acts locally in the gastrointestinal tract against susceptible bacteria, helping manage certain intestinal infections with minimal systemic absorption Ornidazole 400mg is a nitroimidazole antimicrobial effective against susceptible anaerobic bacteria and protozoa, making it useful in mixed gastrointestinal infections This combination is commonly prescribed for the management of acute infectious diarrhea, mixed bacterial and protozoal intestinal infections, traveler's diarrhea (where appropriate), and other gastrointestinal infections as determined by the treating physician Helps reduce symptoms such as diarrhea, abdominal pain, bloating, and intestinal discomfort by targeting susceptible microorganisms Oral tablet formulation offers convenient administration and supports improved patient compliance when taken according to the prescribed dosage and duration Should be used only under medical supervision and for the prescribed course to promote appropriate antimicrobial use. Patients should avoid alcohol during treatment with ornidazole and for at least 48 hours after completing therapy due to the risk of disulfiram-like reactions. The combination is not indicated for viral diarrhea Frequently utilized in gastroenterology clinics, general medicine practices, hospitals, and community healthcare settings Widely prescribed by gastroenterologists and general physicians for appropriate gastrointestinal infections This strengthens a comprehensive gastrointestinal and anti-infective portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Rifaximin 200mg + Ornidazole 400mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from consistent prescription demand, growing gastrointestinal healthcare market opportunities, reliable supply chain support, repeat business, and attractive margins in the anti-infective segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality gastrointestinal and anti-infective pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.